KRTCAP2 antibody (C-Term)
Quick Overview for KRTCAP2 antibody (C-Term) (ABIN953121)
Target
Reactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 131-162, C-Term
-
Specificity
- This antibody reacts to KTAP2.
-
Cross-Reactivity (Details)
- Species reactivity (tested):Human and Mouse.
-
Purification
- Affinity chromatography on Protein A
-
Immunogen
- KLH conjugated synthetic peptide between 131-162 amino acids from the C-terminal region of human KTAP2
-
Isotype
- Ig Fraction
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS, 0.09 % (W/V) sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- KRTCAP2 (Keratinocyte Associated Protein 2 (KRTCAP2))
-
Alternative Name
- KRTCAP2 / KCP2
-
Background
- E3 ubiquitin-protein ligase which accepts ubiquitin from E2 ubiquitin-conjugating enzymes UBE2L3 and UBE2L6 in the form of a thioester and then directly transfers the ubiquitin to targeted substrates, such as UCKL1. Involved in the cytolytic activity of natural killer cells and cytotoxic T-cells.Synonyms: KCP-2, Keratinocyte-associated protein 2
-
Molecular Weight
- 17595 Da
-
Gene ID
- 200185
-
NCBI Accession
- NP_776251
Target
-